OncoSec was incorporated in the state of Nevada in 2011.

OncoSec’s stock is traded on the NASDAQ Capital Market under the symbol ONCS.

Shares can be purchased through a licensed stockbroker or an online trading account. OncoSec does not have a direct stock purchase plan.

The CUSIP number of OncoSec’s common stock is 68234L207.

Not currently. OncoSec is a speculative growth stock. Dividends are normally paid from earnings and OncoSec does not currently generate earnings and profits.

Please visit www.oncosec.com or contact investor relations directly at investors@oncosec.com.

Visit our events page at www.oncosec.com/events and join our mailing list to be notified of upcoming presentations.

OncoSec’s fiscal year ends July 31.

OncoSec’s headquarters are located at 3565 General Atomics Ct., San Diego, CA 92121. The main phone for this location is (858) 662-6732.

OncoSec is covered by the analysts listed below. For more information, please visit: http://ir.oncosec.com/analyst-coverage.

Mark Breidenbach - H.C. Wainwright
Jason Kolbert – Maxim Group
Rahul Jasuja – Noble Life Science Partners

Mayer Hoffman McCann P.C.

10616 Scripps Summit Court
San Diego, CA 92131

Morrison & Foerster LLP
12531 High Bluff Drive
San Diego, CA 92130

Nevada Agency and Transfer Company
50 W. Liberty St.
Suite 880
Reno, NV 89501
P: 775-322-0626